Cargando…
Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562]
Autores principales: | Dieter, Kathrin, Niebergall-Roth, Elke, Daniele, Cristina, Fluhr, Silvia, Frank, Natasha Y., Ganss, Christoph, Kiritsi, Dimitra, McGrath, John A., Tolar, Jakub, Frank, Markus H., Kluth, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581616/ https://www.ncbi.nlm.nih.gov/pubmed/37517864 http://dx.doi.org/10.1016/j.jcyt.2023.06.001 |
Ejemplares similares
-
Clinical trial of ABCB5(+) mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2021) -
Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5(+) Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
por: Niebergall-Roth, Elke, et al.
Publicado: (2023) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014) -
Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa
por: Perdoni, Christopher, et al.
Publicado: (2014) -
Advances in understanding and treating dystrophic epidermolysis bullosa
por: Vanden Oever, Michael J, et al.
Publicado: (2014)